4.7 Article

Convergence of signalling pathways in innate immune responses and genetic forms of Parkinson's disease

Related references

Note: Only part of the references are listed.
Review Immunology

Inflammation and immune dysfunction in Parkinson disease

Malu Gamez Tansey et al.

Summary: This review explores the role of an ageing immune system, host genetics, and exposure to environmental stressors in promoting the development of Parkinson's disease. It discusses the presence of neuroinflammation and alterations in immune cell populations as well as the potential contributions of viral or bacterial exposure, pesticides, and gut microbiota to disease pathogenesis.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Clinical Neurology

Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease

Stephen Mullin et al.

Summary: The study found that carriers of glucocerebrosidase gene mutations without Parkinson's disease also present neuroinflammation. Microglial activation was observed in brain regions susceptible to Lewy pathology. Importantly, the degree of hyposmia was positively correlated with nigral binding potential.

MOVEMENT DISORDERS (2021)

Review Neurosciences

Infection and Risk of Parkinson's Disease

Richard J. Smeyne et al.

Summary: Parkinson's disease is believed to be caused by a combination of genetic and environmental factors, with bacterial or viral infections potentially playing a role as risk factors. Epidemiologic evidence suggests an association between PD and hepatitis C virus, as well as a possible connection to Helicobacter pylori infection. Further research is needed to understand the role of infectious agents in PD development.

JOURNAL OF PARKINSONS DISEASE (2021)

Review Clinical Neurology

Periphery and brain, innate and adaptive immunity in Parkinson's disease

Ashley S. Harms et al.

Summary: Parkinson's disease involves both neuronal events and a significant immune component, with changes in the immune system occurring in both the central nervous system and the periphery. Alpha-synuclein plays a crucial role in activating the innate and adaptive immune system, contributing to neuronal degeneration and symptomatology in patients.

ACTA NEUROPATHOLOGICA (2021)

Review Immunology

The impact of ageing on monocytes and macrophages

Roel P. H. De Maeyer et al.

Summary: Ageing is associated with increased incidence of infections and cancer, decreased vaccine efficacy, immunosenescence, and systemic chronic inflammation. Monocytes and macrophages play a crucial role in immunosenescence and inflammageing, with changes in their phenotype and function contributing to defective immunity with age.

IMMUNOLOGY LETTERS (2021)

Review Biochemistry & Molecular Biology

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease

Jun Ho Lee et al.

Summary: Alzheimer's disease and Parkinson's disease, the most common neurodegenerative diseases, are associated with the release of NLRP3 inflammasome-mediated proinflammatory cytokines by the excessive activation of microglia. Although studies suggest that the NLRP3 inflammasome plays an important role in disease development, its exact function and regulation are still unclear. Studies on natural products show promise as a potential strategy for treating these diseases by regulating NLRP3 inflammasome assembly.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Pharmacology & Pharmacy

Neurodegenerative Disease and the NLRP3 Inflammasome

Jonathan A. Holbrook et al.

Summary: The prevalence of neurodegenerative diseases is increasing, characterized by progressive neuronal loss, protein aggregation, metabolic abnormalities, and immune dysregulation. Research has shown that low-grade systemic inflammation may impact the development and progression of these diseases, and inflammation may also be a causative factor.

FRONTIERS IN PHARMACOLOGY (2021)

Article Neurosciences

In silico comparative analysis of LRRK2 interactomes from brain, kidney and lung

Amrita Verma et al.

Summary: Mutations in LRRK2 are a common cause of familial Parkinson's disease and risk factors for idiopathic PD. Therapeutic agents targeting LRRK2 are in advanced clinical trials, but understanding the broader implications of LRRK2 targeted treatments is crucial. In this study, seven potential targets for investigating LRRK2 in PD were identified, with minimal impact on peripheral organ function. This computational analysis suggests new avenues for experimental investigations in LRRK2-targeted therapeutics.

BRAIN RESEARCH (2021)

Article Medicine, Research & Experimental

LAG3 is not expressed in human and murine neurons and does not modulate α-synucleinopathies

Marc Emmenegger et al.

Summary: The expression pattern of LAG3 in human and mouse brains was analyzed, with no evidence of neurons expressing LAG3. While LAG3 was confirmed to interact with alpha-synuclein fibrils, the specificity of this interaction appears limited. Additionally, overexpression of LAG3 did not worsen alpha-synuclein pathology.

EMBO MOLECULAR MEDICINE (2021)

Review Biochemistry & Molecular Biology

Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease

Antonella Cardinale et al.

Summary: Parkinson's disease is characterized by the aggregation of alpha-synuclein protein in brain regions and the loss of dopaminergic neurons, which leads to synaptic alterations and immune system activation. Toxic species of alpha-syn, such as oligomers and protofibrils, impair synaptic protein distribution and neurotransmitter release, while inflammatory response mediated by microglia and astrocytes is linked to alpha-syn accumulation in the central nervous system.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Fine mapping of the HLA locus in Parkinson's disease in Europeans

Eric Yu et al.

Summary: Specific HLA-DRB1 variants are associated with reduced risk of Parkinson's disease, primarily driven by three specific amino acid polymorphisms. Although the effect size is small, this association provides insights into the role of the immune system in PD.

NPJ PARKINSONS DISEASE (2021)

Letter Virology

Is the brain a reservoir organ for SARS2-CoV2?

Ulises Gomez-Pinedo et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Review Clinical Neurology

Parkinson disease and the immune system - associations, mechanisms and therapeutics

Eng-King Tan et al.

NATURE REVIEWS NEUROLOGY (2020)

Review Neurosciences

Immunotherapy for Parkinson's disease

Aaron D. Schwab et al.

NEUROBIOLOGY OF DISEASE (2020)

Review Neurosciences

Genetics of Parkinson's disease: An introspection of its journey towards precision medicine

Sara Bandres-Ciga et al.

NEUROBIOLOGY OF DISEASE (2020)

Article Clinical Neurology

Nonsteroidal Anti-Inflammatory Use and LRRK2 Parkinson's Disease Penetrance

Marta San Luciano et al.

MOVEMENT DISORDERS (2020)

Article Multidisciplinary Sciences

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Jerome Hadjadj et al.

SCIENCE (2020)

Article Biochemistry & Molecular Biology

Cellular calcium signaling in the aging brain

Remya Chandran et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2019)

Review Gastroenterology & Hepatology

The risk of Parkinson's disease in inflammatory bowel disease: A systematic review and meta-analysis

Feng Zhu et al.

DIGESTIVE AND LIVER DISEASE (2019)

Editorial Material Geriatrics & Gerontology

Human Inflammaging

Tamas Fulop et al.

GERONTOLOGY (2019)

Review Immunology

Exploring the Multiple-Hit Hypothesis of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat

Kristin L. Patrick et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)

Article Cell & Tissue Engineering

Involvement of p38 in Age-Related Decline in Adult Neurogenesis via Modulation of Wnt Signaling

Yoshitaka Kase et al.

STEM CELL REPORTS (2019)

Article Cell Biology

Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent manner

Bojan Shutinoski et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease

Paraskevi Krashia et al.

NATURE COMMUNICATIONS (2019)

Editorial Material Cell Biology

sFRP3 inhibition improves age-related cellular changes in BubR1 progeroid mice

Chang Hoon Cho et al.

AGING CELL (2019)

Review Biochemistry & Molecular Biology

The role of LRRK2 in cell signalling

Kirsten Harvey et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2019)

Review Geriatrics & Gerontology

The potential role of necroptosis in inflammaging and aging

Gordon H. Royce et al.

GEROSCIENCE (2019)

Review Neurosciences

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis

Michaela E. Johnson et al.

TRENDS IN NEUROSCIENCES (2019)

Review Neurosciences

LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same

Daniel C. Berwick et al.

MOLECULAR NEURODEGENERATION (2019)

Review Immunology

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells

Francesca Garretti et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Geriatrics & Gerontology

Aging leads to dysfunctional innate immune responses to TLR2 and TLR4 agonists

Kristina L. Bailey et al.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2019)

Review Cell Biology

Genetic risk factors in Parkinson's disease

K. J. Billingsley et al.

CELL AND TISSUE RESEARCH (2018)

Article Multidisciplinary Sciences

Regulation of myeloid cell phagocytosis by LRRK2 via WAVE2 complex stabilization is altered in Parkinson's disease

Kwang Soo Kim et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Review Immunology

Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease

Geraldine Gelders et al.

JOURNAL OF IMMUNOLOGY RESEARCH (2018)

Article Multidisciplinary Sciences

Parkin and PINK1 mitigate STING-induced inflammation

Danielle A. Sliter et al.

NATURE (2018)

Review Neurosciences

Inflammasome signalling in brain function and neurodegenerative disease

Michael T. Heneka et al.

NATURE REVIEWS NEUROSCIENCE (2018)

Article Cell Biology

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Richard Gordon et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Neurosciences

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Sara Bachiller et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2018)

Article Geriatrics & Gerontology

Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62Ldim Immunosuppressive Subset

Delphine Sauce et al.

JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2017)

Article Multidisciplinary Sciences

T cells from patients with Parkinson's disease recognize α-synuclein peptides

David Sulzer et al.

NATURE (2017)

Article Clinical Neurology

Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases

Aree Witoelar et al.

JAMA NEUROLOGY (2017)

Article Neurosciences

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia

Tatsunori Maekawa et al.

BMC NEUROSCIENCE (2016)

Article Biochemistry & Molecular Biology

Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson's Disease

Timothy R. Sampson et al.

Article Geriatrics & Gerontology

Host Resistance and Immune Aging

Thilinie Bandaranayake et al.

CLINICS IN GERIATRIC MEDICINE (2016)

Article Pharmacology & Pharmacy

Immunomodulation as a neuroprotective and therapeutic strategy for Parkinson's disease

Katherine E. Olson et al.

CURRENT OPINION IN PHARMACOLOGY (2016)

Article Endocrinology & Metabolism

Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients

Delson Jose da Silva et al.

NEUROIMMUNOMODULATION (2016)

Letter Neurosciences

LRRK2 contributes to monocyte dysregulation in Parkinson's disease

Corinna Bliederhaeuser et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2016)

Review Cell Biology

Role of Genetic Alterations in the NLRP3 and CARD8 Genes in Health and Disease

G. V. Paramel et al.

MEDIATORS OF INFLAMMATION (2015)

Article Geriatrics & Gerontology

Downregulation of canonical Wnt signaling in hippocampus of SAMP8 mice

Sergi Bayod et al.

NEUROBIOLOGY OF AGING (2015)

Review Geriatrics & Gerontology

Innate immunesenescence: underlying mechanisms and clinical relevance

Jon Hazeldine et al.

BIOGERONTOLOGY (2015)

Review Immunology

STING: infection, inflammation and cancer

Glen N. Barber

NATURE REVIEWS IMMUNOLOGY (2015)

Article Biochemistry & Molecular Biology

Functional interplay between Parkin and Drp1 in mitochondrial fission and clearance

Lori Buhlman et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)

Review Geriatrics & Gerontology

Role of dendritic cells in innate and adaptive immune response in human aging

Sudhir Gupta

EXPERIMENTAL GERONTOLOGY (2014)

Article Biochemistry & Molecular Biology

A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific β-Tubulin Isoforms Regulates Tubulin Acetylation

Bernard M. H. Law et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2014)

Article Cell Biology

PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity

Lesley A. Kane et al.

JOURNAL OF CELL BIOLOGY (2014)

Review Oncology

Inflammatory response in Parkinson's disease

Junqiang Yan et al.

MOLECULAR MEDICINE REPORTS (2014)

Article Clinical Neurology

Early-onset Parkinson's disease due to PINK1 p.Q456X mutation - Clinical and functional study

Joanna Siuda et al.

PARKINSONISM & RELATED DISORDERS (2014)

Review Cell Biology

The regulation and deregulation of Wnt signaling by PARK genes in health and disease

Daniel C. Berwick et al.

JOURNAL OF MOLECULAR CELL BIOLOGY (2014)

Article Genetics & Heredity

Association of Parkinson Disease with Structural and Regulatory Variants in the HLA Region

William T. Wissemann et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2013)

Review Immunology

Pattern recognition receptor function in neutrophils

Christina J. Thomas et al.

TRENDS IN IMMUNOLOGY (2013)

Article Multidisciplinary Sciences

Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Changyoun Kim et al.

NATURE COMMUNICATIONS (2013)

Review Neurosciences

The Role of Innate and Adaptive Immunity in Parkinson's Disease

George T. Kannarkat et al.

JOURNAL OF PARKINSONS DISEASE (2013)

Review Immunology

Age-dependent dysregulation of innate immunity

Albert C. Shaw et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Article Biochemistry & Molecular Biology

The importance of Wnt signalling for neurodegeneration in Parkinson's disease

Daniel C. Berwick et al.

BIOCHEMICAL SOCIETY TRANSACTIONS (2012)

Article Neurosciences

Wnt3a induces exosome secretion from primary cultured rat microglia

Claudie Hooper et al.

BMC NEUROSCIENCE (2012)

Article Psychology, Biological

Reduced neutrophil superoxide production among healthy older adults in response to acute psychological stress

Riyad Khanfer et al.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY (2012)

Article Neurosciences

LRRK2 Inhibition Attenuates Microglial Inflammatory Responses

Mark S. Moehle et al.

JOURNAL OF NEUROSCIENCE (2012)

Article Multidisciplinary Sciences

Gaucher disease gene GBA functions in immune regulation

Jun Liu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Review Cell Biology

Wnt signaling in macrophages: Augmenting and inhibiting mycobacteria-induced inflammatory responses

Kolja Schaale et al.

EUROPEAN JOURNAL OF CELL BIOLOGY (2011)

Article Neurosciences

WNT Signaling in Activated Microglia Is Proinflammatory

Carina Halleskog et al.

Article Public, Environmental & Occupational Health

Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Parkinson's Disease

Angelika D. Manthripragada et al.

NEUROEPIDEMIOLOGY (2011)

Article Clinical Neurology

Use of ibuprofen and risk of Parkinson disease

Xiang Gao et al.

NEUROLOGY (2011)

Article Multidisciplinary Sciences

Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts

Aleksandar Rakovic et al.

PLOS ONE (2011)

Article Immunology

Impaired Functions of Peripheral Blood Monocyte Subpopulations in Aged Humans

Joseph Nyugen et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2010)

Article Immunology

LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens

Agnes Gardet et al.

JOURNAL OF IMMUNOLOGY (2010)

Article Biochemistry & Molecular Biology

MKK6 binds and regulates expression of Parkinson's disease-related protein LRRK2

Cindy H. Hsu et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Article Immunology

Peripheral cytokines profile in Parkinson's disease

M. Reale et al.

BRAIN BEHAVIOR AND IMMUNITY (2009)

Article Peripheral Vascular Disease

The Wnt pathway: A macrophage effector molecule that triggers inflammation

Claudia P. Pereira et al.

CURRENT ATHEROSCLEROSIS REPORTS (2009)

Article Biochemistry & Molecular Biology

Mutations in the LRRK2 Roc-COR tandem domain link Parkinson's disease to Wnt signalling pathways

Rosa M. Sancho et al.

HUMAN MOLECULAR GENETICS (2009)

Review Biochemistry & Molecular Biology

Parkinson's disease: from monogenic forms to genetic susceptibility factors

Suzanne Lesage et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

The Parkinson disease-associated protein kinase LRRK2 exhibits MAPKKK activity and phosphorylates MKK3/6 and MKK4/7, in vitro

Christian Johannes Gloeckner et al.

JOURNAL OF NEUROCHEMISTRY (2009)

Article Cell Biology

Parkin is recruited selectively to impaired mitochondria and promotes their autophagy

Derek Narendra et al.

JOURNAL OF CELL BIOLOGY (2008)

Review Geriatrics & Gerontology

Aging and Neutrophils: There Is Still Much To Do

Carl F. Fortin et al.

REJUVENATION RESEARCH (2008)

Review Immunology

WNT signalling in the immune system: WNT is spreading its wings

Frank J. T. Staal et al.

NATURE REVIEWS IMMUNOLOGY (2008)

Review Pharmacology & Pharmacy

The parkin protein as a therapeutic target in Parkinson's disease

Konstanze F. Winklhofer

EXPERT OPINION ON THERAPEUTIC TARGETS (2007)

Article Multidisciplinary Sciences

Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

Anamitra Ghosh et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Clinical Neurology

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease

Angelika D. Wahner et al.

NEUROLOGY (2007)

Article Neurosciences

Involvement of interferon-γ in microglial-mediated loss of dopaminergic neurons

Matthew P. Mount et al.

JOURNAL OF NEUROSCIENCE (2007)

Article Neurosciences

P53 protein, interferon-γ, and NF-κB levels are elevated in the parkinsonian brain

Makio Mogi et al.

NEUROSCIENCE LETTERS (2007)

Article Immunology

Age-associated defect in human TLR-1/2 function

David van Duin et al.

JOURNAL OF IMMUNOLOGY (2007)

Article Multidisciplinary Sciences

Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin

Jeehye Park et al.

NATURE (2006)

Article Multidisciplinary Sciences

Mutations in PTEN-induced putative kinase 1 associated with recessive parkinsonism have differential effects on protein stability

A Beilina et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Genetics & Heredity

Interaction of polymorphisms in the genes encoding interleukin-6 and estrogen receptor beta on the susceptibility to Parkinson's disease

A Håkansson et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2005)

Article Biochemistry & Molecular Biology

PINK1, Parkin, and DJ-1 mutations in Italian patients with early-onset parkinsonism

C Klein et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2005)

Article Clinical Neurology

Novel PINK1 mutations in early-onset parkinsonism

Y Hatano et al.

ANNALS OF NEUROLOGY (2004)

Article Clinical Neurology

Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease

E Rogaeva et al.

ARCHIVES OF NEUROLOGY (2004)

Review Geriatrics & Gerontology

Staging of brain pathology related to sporadic Parkinson's disease

H Braak et al.

NEUROBIOLOGY OF AGING (2003)

Article Clinical Neurology

HLA typing and Parkinson's disease

JB Lampe et al.

EUROPEAN NEUROLOGY (2003)

Article Immunology

Cutting edge: Impaired toll-like receptor expression and function in aging

M Renshaw et al.

JOURNAL OF IMMUNOLOGY (2002)

Article Clinical Neurology

A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1

M Funayama et al.

ANNALS OF NEUROLOGY (2002)

Article Biochemistry & Molecular Biology

α-Synuclein affects the MAPK pathway and accelerates cell death

A Iwata et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)

Article Biochemistry & Molecular Biology

Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease

SM Kulich et al.

JOURNAL OF NEUROCHEMISTRY (2001)

Article Medicine, Research & Experimental

NF-κB in neuronal plasticity and neurodegenerative disorders

MP Mattson et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)

Article Clinical Neurology

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

R Kruger et al.

JOURNAL OF NEURAL TRANSMISSION (2000)